Best-Selling Ivermectin Products
A Peer-Reviewed Cancer Study. A Number Worth Reading.
In a first-of-its-kind observational study, 122 cancer patients using TWC's Ivermectin + Mebendazole were followed for six months. 84.4% reported clinical benefit, including tumor shrinkage or no evidence of disease. Published in Anticancer Research Journal and available on PubMed.
FDA Approved Ivermectin
- FDA-approved anti-parasitic medication
- Treats river blindness and strongyloidiasis
- Used since the 1980s
- Recognized for efficacy and safety
Safe & Effective
- Well-established safety profile
- Has benefited millions worldwide
- Decades of real-world data confirm its effectiveness
- Important for global health
Our Ivermectin
- Tested for purity
- Prescribed by a licensed provider
- Dye-Free
- Compounded & dispensed by a 50-state licensed pharmacy
What Our Doctors Are Saying
Don't Fall for Counterfeits
According to the National Association of Boards of Pharmacy (CDC), ensuring the safety and authenticity of medications is more critical than ever. The risk of counterfeit or substandard drugs is high, making it essential to source medications from a trusted provider.
The Wellness Company stands out as a reliable source for ivermectin by maintaining strict quality and safety standards. They ensure all medications come from licensed pharmacies and are dispensed only by qualified healthcare professionals, eliminating the dangers of counterfeit or improperly formulated drugs.
Beyond just providing safe medications, The Wellness Company prioritizes transparency. They offer clear, verifiable information about their products, where they are sourced, and the medical professionals involved in prescribing them. This commitment to openness and safety gives patients the confidence they need when seeking reliable treatment options.
The Science Behind Ivermectin
COVID-19 Treatment
A meta-analysis reviewed multiple clinical trials assessing ivermectin's potential effects on COVID-19 outcomes. Findings suggest possible benefits, though further research is needed.
Parasite Cleanse
A review highlights ivermectin's longstanding use in treating various parasitic infections, emphasizing its safety and broad-spectrum effectiveness.
Anti-Viral
A systematic review explores ivermectin's antiviral properties, noting in vitro effects on viral replication, though in vivo results remain inconsistent.
Heidary, F., & Gharebaghi, R. (2020).
Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. The Journal of Antibiotics, 73(9), 593–602.
Rahman, M. A., Iqbal, M. S., Islam, M. A., et al. (2020).
Comparison of Viral Clearance Between Ivermectin with Doxycycline and Hydroxychloroquine with Azithromycin in COVID-19 Patients: A Randomized Controlled Trial. Journal of Bangladesh College of Physicians and Surgeons, 38(S1), 5–9.
Alam, M. T., Murshed, R., Bhiuyan, E., et al. (2020).
A Case Series of 100 COVID-19 Positive Patients Treated with Combination of Ivermectin and Doxycycline. Journal of Bangladesh College of Physicians and Surgeons, 38(S1), 10–15.
Gorial, F. I., Mashhadani, S., Sayaly, H. M., et al. (2020).
Effectiveness of Ivermectin as Add-On Therapy in COVID-19 Management (Pilot Trial). medRxiv.
Chowdhury, A. T. M. M., Shahbaz, M., Karim, M. R., et al. (2020).
A Randomized Trial of Ivermectin-Doxycycline and Hydroxychloroquine-Azithromycin Therapy on COVID19 Patients. Research Square.
Nunez, M., Aguirre, C., Maturana, D., et al. (2020).
Ivermectin as Prophylaxis Against COVID-19 Retrospective Cases Evaluation. ResearchGate
Khan, M. S. I., Khan, M. S. I., Debnath, C. R., et al. (2020).
Ivermectin Treatment May Improve the Prognosis of Patients with COVID-19. Archives of Bronconeumology, 56(12), 828–830.
Rajter, J. C., Sherman, M. S., Fatteh, N., et al. (2021).
Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study. Chest, 159(1), 85–92.
Schmith, V. D., Zhou, J. J., & Lohmer, L. R. L. (2020).
The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19. Clinical Pharmacology & Therapeutics, 108(4), 762–765.
You May Also Like
